Search Results

There are 4071 results for: content related to: Variants in interferon-alpha pathway genes and response to pegylated interferon-Alpha2a plus ribavirin for treatment of chronic hepatitis C virus infection in the hepatitis C antiviral long-term treatment against cirrhosis trial

  1. You have free access to this content
    Outcome of sustained virological responders with histologically advanced chronic hepatitis C

    Hepatology

    Volume 52, Issue 3, September 2010, Pages: 833–844, Timothy R. Morgan, Marc G. Ghany, Hae-Young Kim, Kristin K. Snow, Mitchell L. Shiffman, Jennifer L. De Santo, William M. Lee, Adrian M. Di Bisceglie, Herbert L. Bonkovsky, Jules L. Dienstag, Chihiro Morishima, Karen L. Lindsay, Anna S. F. Lok and and the HALT-C Trial Group

    Version of Record online : 14 MAY 2010, DOI: 10.1002/hep.23744

  2. You have free access to this content
    Fibrosis progression in chronic hepatitis C: Morphometric image analysis in the HALT-C trial

    Hepatology

    Volume 50, Issue 6, December 2009, Pages: 1738–1749, Zachary D. Goodman, Anne M. Stoddard, Herbert L. Bonkovsky, Robert J. Fontana, Marc G. Ghany, Timothy R. Morgan, Elizabeth C. Wright, Elizabeth M. Brunt, David E. Kleiner, Mitchell L. Shiffman, Gregory T. Everson, Karen L. Lindsay, Jules L. Dienstag, Chihiro Morishima and HALT-C Trial Group

    Version of Record online : 5 AUG 2009, DOI: 10.1002/hep.23211

  3. You have free access to this content
    Predicting clinical outcomes using baseline and follow-up laboratory data from the hepatitis C long-term treatment against cirrhosis trial

    Hepatology

    Volume 54, Issue 5, November 2011, Pages: 1527–1537, Marc G. Ghany, Hae-Young Kim, Anne Stoddard, Elizabeth C. Wright, Leonard B. Seeff, Anna S.F. Lok and the HALT-C Trial Group

    Version of Record online : 28 OCT 2011, DOI: 10.1002/hep.24550

  4. You have free access to this content
    Coffee intake is associated with lower rates of liver disease progression in chronic hepatitis C

    Hepatology

    Volume 50, Issue 5, November 2009, Pages: 1360–1369, Neal D. Freedman, James E. Everhart, Karen L. Lindsay, Marc G. Ghany, Teresa M. Curto, Mitchell L. Shiffman, William M. Lee, Anna S. Lok, Adrian M. Di Bisceglie, Herbert L. Bonkovsky, John C. Hoefs, Jules L. Dienstag, Chihiro Morishima, Christian C. Abnet, Rashmi Sinha and HALT-C Trial Group

    Version of Record online : 13 JUL 2009, DOI: 10.1002/hep.23162

  5. You have free access to this content
    Excess mortality in patients with advanced chronic hepatitis C treated with long-term peginterferon

    Hepatology

    Volume 53, Issue 4, April 2011, Pages: 1100–1108, Adrian M. Di Bisceglie, Anne M. Stoddard, Jules L. Dienstag, Mitchell L. Shiffman, Leonard B. Seeff, Herbert L. Bonkovsky, Chihiro Morishima, Elizabeth C. Wright, Kristin K. Snow, William M. Lee, Robert J. Fontana, Timothy R. Morgan, Marc G. Ghany and for the HALT-C Trial Group

    Version of Record online : 7 APR 2011, DOI: 10.1002/hep.24169

  6. You have free access to this content
    Prognostic value of Ishak fibrosis stage: Findings from the hepatitis C antiviral long-term treatment against cirrhosis trial

    Hepatology

    Volume 51, Issue 2, February 2010, Pages: 585–594, James E. Everhart, Elizabeth C. Wright, Zachary D. Goodman, Jules L. Dienstag, John C. Hoefs, David E. Kleiner, Marc G. Ghany, A. Scott Mills, S. Russell Nash, Sugantha Govindarajan, Thomas E. Rogers, Joel K. Greenson, Elizabeth M. Brunt, Herbert L. Bonkovsky, Chihiro Morishima, Heather J. Litman and HALT-C Trial Group

    Version of Record online : 14 SEP 2009, DOI: 10.1002/hep.23315

  7. You have free access to this content
    Evolution of hepatic steatosis in patients with advanced hepatitis C: Results from the hepatitis C antiviral long-term treatment against cirrhosis (HALT-C) trial

    Hepatology

    Volume 49, Issue 6, June 2009, Pages: 1828–1837, Anna S. Lok, James E. Everhart, Raymond T. Chung, Hae-Young Kim, Gregory T. Everson, John C. Hoefs, Joel K. Greenson, Richard K. Sterling, Karen L. Lindsay, William M. Lee, Adrian M. Di Bisceglie, Herbert L. Bonkovsky, Marc G. Ghany, Chihiro Morishima and HALT-C Trial Group

    Version of Record online : 2 FEB 2009, DOI: 10.1002/hep.22865

  8. You have free access to this content
    Relationship of serum fibrosis markers with liver fibrosis stage and collagen content in patients with advanced chronic hepatitis C

    Hepatology

    Volume 47, Issue 3, March 2008, Pages: 789–798, Robert J. Fontana, Zachary D. Goodman, Jules L. Dienstag, Herbert L. Bonkovsky, Deepa Naishadham, Richard K. Sterling, Grace L. Su, Mita Ghosh, Elizabeth C. Wright and HALT-C Trial Group

    Version of Record online : 3 JAN 2008, DOI: 10.1002/hep.22099

  9. You have free access to this content
    Changes in quality of life and sexual health are associated with low-dose peginterferon therapy and disease progression in patients with chronic hepatitis C

    Alimentary Pharmacology & Therapeutics

    Volume 31, Issue 7, April 2010, Pages: 719–734, K. K. SNOW, H. L. BONKOVSKY, R. J. FONTANA, H.-Y. KIM, R. K. STERLING, A. M. DI BISCEGLIE, T. R. MORGAN, J. L. DIENSTAG, M. G. GHANY and The HALT-C Trial Group

    Version of Record online : 12 JAN 2010, DOI: 10.1111/j.1365-2036.2010.04235.x

  10. You have free access to this content
    Quantitative liver function tests improve the prediction of clinical outcomes in chronic hepatitis C: Results from the hepatitis C antiviral long-term treatment against cirrhosis trial

    Hepatology

    Volume 55, Issue 4, April 2012, Pages: 1019–1029, Gregory T. Everson, Mitchell L. Shiffman, John C. Hoefs, Timothy R. Morgan, Richard K. Sterling, David A. Wagner, Shannon Lauriski, Teresa M. Curto, Anne Stoddard, Elizabeth C. Wright and the HALT-C Trial Group

    Version of Record online : 1 MAR 2012, DOI: 10.1002/hep.24752

  11. Antigen-specific T lymphocyte proliferation decreases over time in advanced chronic hepatitis C

    Journal of Viral Hepatitis

    Volume 19, Issue 6, June 2012, Pages: 404–413, C. Morishima, A. M. Di Bisceglie, A. L. Rothman, H. L. Bonkovsky, K. L. Lindsay, W. M. Lee, M. J. Koziel, R. J. Fontana, H.-Y. Kim, E. C. Wright and the HALT-C Trial Group

    Version of Record online : 16 DEC 2011, DOI: 10.1111/j.1365-2893.2011.01562.x

  12. You have free access to this content
    A prospective study of the rate of progression in compensated, histologically advanced chronic hepatitis C

    Hepatology

    Volume 54, Issue 2, August 2011, Pages: 396–405, Jules L. Dienstag, Marc G. Ghany, Timothy R. Morgan, Adrian M. Di Bisceglie, Herbert L. Bonkovsky, Hae-Young Kim, Leonard B. Seeff, Gyongyi Szabo, Elizabeth C. Wright, Richard K. Sterling, Gregory T. Everson, Karen L. Lindsay, William M. Lee, Anna S. Lok, Chihiro Morishima, Anne M. Stoddard, James E. Everhart and for the HALT-C Trial Group

    Version of Record online : 23 JUN 2011, DOI: 10.1002/hep.24370

  13. You have free access to this content
    Quantitative tests of liver function measure hepatic improvement after sustained virological response: results from the HALT-C trial

    Alimentary Pharmacology & Therapeutics

    Volume 29, Issue 5, March 2009, Pages: 589–601, G. T. EVERSON, M. L. SHIFFMAN, J. C. HOEFS, T. R. MORGAN, R. K. STERLING, D. A. WAGNER, J. L. DESANTO, T. M. CURTO, E. C. WRIGHT and THE HALT-C TRIAL GROUP

    Version of Record online : 1 DEC 2008, DOI: 10.1111/j.1365-2036.2008.03908.x

  14. You have free access to this content
    Occult and previous hepatitis B virus infection are not associated with hepatocellular carcinoma in United States patients with chronic hepatitis C

    Hepatology

    Volume 54, Issue 2, August 2011, Pages: 434–442, Anna S. Lok, James E. Everhart, Adrian M. Di Bisceglie, Hae-Young Kim, Munira Hussain, Timothy R. Morgan and and the HALT-C Trial Group

    Version of Record online : 25 JUL 2011, DOI: 10.1002/hep.24257

  15. You have free access to this content
    Impact of disease severity on outcome of antiviral therapy for chronic hepatitis C: Lessons from the HALT-C trial

    Hepatology

    Volume 44, Issue 6, December 2006, Pages: 1675–1684, Gregory T. Everson, John C. Hoefs, Leonard B. Seeff, Herbert L. Bonkovsky, Deepa Naishadham, Mitchell L. Shiffman, Jeffrey A. Kahn, Anna S. F. Lok, Adrian M. Di Bisceglie, William M. Lee, Jules L. Dienstag, Marc G. Ghany and Chihiro Morishima

    Version of Record online : 28 NOV 2006, DOI: 10.1002/hep.21440

  16. You have free access to this content
    Cognitive function does not worsen during pegylated interferon and ribavirin retreatment of chronic hepatitis C

    Hepatology

    Volume 45, Issue 5, May 2007, Pages: 1154–1163, Robert J. Fontana, Linas A. Bieliauskas, Karen L. Lindsay, Carla Back-Madruga, Elizabeth C. Wright, Kristin K. Snow, Anna S.F. Lok, Ziad Kronfol and Latha Padmanabhan

    Version of Record online : 26 APR 2007, DOI: 10.1002/hep.21633

  17. You have free access to this content
    Silymarin use and liver disease progression in the Hepatitis C Antiviral Long-Term Treatment against Cirrhosis trial

    Alimentary Pharmacology & Therapeutics

    Volume 33, Issue 1, January 2011, Pages: 127–137, N. D. Freedman, T. M. Curto, C. Morishima, L. B. Seeff, Z. D. Goodman, E. C. Wright, R. Sinha, J. E. Everhart and the HALT-C Trial Group

    Version of Record online : 2 NOV 2010, DOI: 10.1111/j.1365-2036.2010.04503.x

  18. You have free access to this content
    Predicting cirrhosis in patients with hepatitis C based on standard laboratory tests: Results of the HALT-C cohort

    Hepatology

    Volume 42, Issue 2, August 2005, Pages: 282–292, Anna S. F. Lok, Marc G. Ghany, Zachary D. Goodman, Elizabeth C. Wright, Gregory T. Everson, Richard K. Sterling, James E. Everhart, Karen L. Lindsay, Herbert L. Bonkovsky, Adrian M. Di Bisceglie, William M. Lee, Timothy R. Morgan, Jules L. Dienstag and Chihiro Morishima

    Version of Record online : 28 JUN 2005, DOI: 10.1002/hep.20772

  19. YKL-40 genetic polymorphisms and the risk of liver disease progression in patients with advanced fibrosis due to chronic hepatitis C

    Liver International

    Volume 32, Issue 4, April 2012, Pages: 665–674, Robert J. Fontana, Heather J. Litman, Jules L. Dienstag, Herbert L. Bonkovsky, Grace Su, Richard K. Sterling, Anna S. Lok and for the HALT-C Trial Group

    Version of Record online : 22 NOV 2011, DOI: 10.1111/j.1478-3231.2011.02686.x

  20. You have free access to this content
    Herbal product use by persons enrolled in the hepatitis C Antiviral Long-Term Treatment Against Cirrhosis (HALT-C) Trial

    Hepatology

    Volume 47, Issue 2, February 2008, Pages: 605–612, Leonard B. Seeff, Teresa M. Curto, Gyongyi Szabo, Gregory T. Everson, Herbert L. Bonkovsky, Jules L. Dienstag, Mitchell L. Shiffman, Karen L. Lindsay, Anna S. F. Lok, Adrian M. Di Bisceglie, William M. Lee and Marc G. Ghany

    Version of Record online : 21 DEC 2007, DOI: 10.1002/hep.22044